Variant detail

KCNQ1F339del

c.1017del · residue 339 · Chr11 2604760
HGVS annotation

ClinVar-style identity and transcript context

ClinVar-style HGVS
NM_000218.3(KCNQ1):c.1017del (F339del)
HGVSc
c.1017del
cDNA change
c.1017del
RefSeq transcript
NM_000218.3
Ensembl transcript
ENST00000155840.12
Protein HGVS
F339del
Genomic coordinate
Chr11 2604760
LQT1 penetrance High risk
79% 90% credible interval 65-91%
0%20%50%100%

Emerging evidence · n=16 13 observed LQT1 carriers · 7.55 hypothetical affected and 2.45 hypothetical unaffected

One-sentence summary

Roughly 8 in 10 people who carry F339del are estimated to eventually be diagnosed with Long QT type 1 — high risk penetrance, based on 16 carriers reported so far.

Structure: NA. Functional class: NA.

Executive summary

Sources used for interpretation

The LQT1 penetrance estimate combines observed carrier counts with a feature-based model starting point. Other rows summarize supporting annotations for interpretation; not every row is a direct input to the model.

Estimatemodel output Observedmeasured in people/assays Model inputassumed, not observed Predictedcomputational Externalthird-party

Evidence

Carriers observed
16
13 LQT1 · 3 unaffected/other · 0 gnomAD
Model prior: 7.55 hypothetical affected · 2.45 hypothetical unaffected
Emerging evidence
Functional data
NA
0 published functional studies
Predictors and density
REVELrange 0-1
LQT1 densityHotspot region0.766range 0-1
PolyPhen-2range 0-1
PROVEANcutoff <= -2.5
BLAST-PSSMlower = less tolerated
Overall0/5
Range labels show the expected scale or cutoff. Calls are rough orientation from published cutoffs (hover a row) — not a clinical classification.

Automated ACMG/AMP review prompts

Generated from available data — not a clinical classification
PS3not met
Published functional studies available
PM1review
Hotspot or high LQT1 density
PM2met · moderate
Absent or extremely rare in population data
PP3not met
Computational predictors support effect
BS1not met
Allele frequency too high for disorder

Reported carrier data

Paper / cohort Carriers LQT1 / affected Unaffected / ambiguous Other observations Variant context
Year 2016 · clinical carrier record
1 1 LQT1 0 asymptomatic Not separately annotated
Variant F339del
Curated carrier-count row
Year 2014 · clinical carrier record
1 1 LQT1 0 asymptomatic Not separately annotated
Variant F339del
Curated carrier-count row
Year 2003 · clinical carrier record
4 0 LQT1 4 asymptomatic Not separately annotated
Variant F339del
Curated carrier-count row
Year 1998 · clinical carrier record
10 10 LQT1 0 asymptomatic Not separately annotated
Variant F339del
Curated carrier-count row
gnomAD population observations (v4) 0 0 LQT1 0 Population observations; not known affected cases. gnomAD v4 allele count.
Combined literature, cohort, and gnomAD 16 13 LQT1 3 Combined totals used in the penetrance estimate. Curated carrier totals for this variant.
Hypothetical observations from model prior (not observed patients) 10 7.55 hypothetical LQT1 affected 2.45 hypothetical unaffected Feature-based pseudo-counts added before observed carriers. Model input; not literature or gnomAD evidence.

Model starting point. The penetrance model starts with 7.55 hypothetical affected and 2.45 hypothetical unaffected observations derived from variant features, then updates that starting point with the real carrier counts above. As observed carrier counts grow, this feature-based starting point has less influence.

Nearby variants · researcher detail
Neighbour residueDistance (A)Observed variants
2719.6
25011.5L250H, L250P,
26611.7L266P,
24711.8T247I,
26211.8L262P, L262R, L262V,
24811.9W248C, W248C, W248R, W248R
27612.5S276del,
25512.7
27412.8I274V,
27513.1F275del,
27014.0F270S,
25414.3V254M, V254L, V254L,
25214.4G252R,
26314.4
33914.5F339del, F339S,
34114.7A341V, A341E,
25814.8H258P, H258N, H258R, H258Y,
33415.0V334A,
External resources